Academic Journal
Q1European Journal of Pharmacology
About European Journal of Pharmacology
European Journal of Pharmacology is a scholarly journal published by Elsevier B.V.. SCImago 2025 places it in Q1 with an SJR of 1.357 and an H-index of 217.
Its listed coverage is 1967-2026 and its research categories include Pharmacology (Q1). The 2025 dataset reports 1026 documents and 11138 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Receptor Mechanisms and Signaling, Neuroscience and Neuropharmacology Research, Neuropeptides and Animal Physiology, Neurotransmitter Receptor Influence on Behavior, Ion channel regulation and function, Nitric Oxide and Endothelin Effects.
Recent Research Articles
Latest publications matched automatically by ISSN.
Inhibition of CXCR4-induced angiogenesis to block choroidal neovascularization and restore retinal function in age-related macular degeneration by in silico-selected small molecules
Shih-Jie Chou, Chia-Hao Wang, Ping-Hsing Tsai, Yu-Jer Hsiao et al.
2026-10 · DOI: 10.1016/j.ejphar.2026.179236Neuropharmacological and behavioral characterization of 3F-phenetrazine, a novel amphetamine-like substance, in male mice and rats
Sumin Ban, Kyung Oh Jeon, Su Yeon Seo, Young Ju Do et al.
2026-10 · DOI: 10.1016/j.ejphar.2026.179253ASC-J9 attenuates the metastatic potential of oral cancer cells by downregulating the STAT3/ITGB8 signaling pathway
Pei-Ni Chen, Chiao-Wen Lin, Chih-Ting Lai, Shun-Fa Yang et al.
2026-10 · DOI: 10.1016/j.ejphar.2026.179306Mitochondrial dysfunction in ifosfamide-induced nephrotoxicity: Mechanisms and possible interventions
Kate Liang, Jolita Ciapaite, Rosalinde Masereeuw, Marianne C. Verhaar et al.
2026-10 · DOI: 10.1016/j.ejphar.2026.179269A phase I clinical study of the safety, tolerability, pharmacokinetics and pharmacodynamics of SHR-2106, an anti-CD40 antibody, following single intravenous or subcutaneous administration in healthy participants
Jie Huang, Qiang-da Huang, Jin-lian Xie, Qian Wu et al.
2026-10 · DOI: 10.1016/j.ejphar.2026.179291Binding capacity of Intravenous immunoglobulin G to BK polyomavirus determines its anti-BK polyomavirus activity in infected cultures
Noriaki Sato, Atsuko Shiraki, Masaya Takemoto, Yoshinori Takemura et al.
2026-10 · DOI: 10.1016/j.ejphar.2026.179248Memantine modulates TRPM3-associated glutamatergic signaling via vGLUT2 in a mouse model of obsessive-compulsive disorder
Prerana V. Chaudhari, Sanjay N. Awathale, Sachin R. Ahire, Rashid Ansari et al.
2026-10 · DOI: 10.1016/j.ejphar.2026.179238GLUT1/SGLT1 balance associates with high-glucose buffering of metformin-induced lysosomal deacidification and mTORC1 inhibition in colorectal cancer
Badr-Eddine Allal, Susana Mendonça, Abdelkader Bounaama, Paula Fresco et al.
2026-10 · DOI: 10.1016/j.ejphar.2026.179242Imidazo[1,2-a]pyridine-based HDAC6 inhibitor a17 for the treatment of Alzheimer's disease
Zhe Han, Wenmin Liu, Wenling Fu, Keren Wang et al.
2026-10 · DOI: 10.1016/j.ejphar.2026.179320Isoginkgetin ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via the SIRT1/NRF2 pathway
Hongwei Mo, Han Su, Zhenyu Zhuang, Junjie Guan et al.
2026-10 · DOI: 10.1016/j.ejphar.2026.179252AMPK as a central node in cancer and cardiovascular diseases
Yuehan Long, Zong Li, Wen-Bin Ou
2026-10 · DOI: 10.1016/j.ejphar.2026.179300Schisandrin B attenuates doxorubicin-induced acute cardiac injury through regulation of metabolites and gut microbiota
Huixin Qiu, Xiangying Wang, Jun Qian, Shumin Zhang et al.
2026-10 · DOI: 10.1016/j.ejphar.2026.179246Attenuated Salmonella typhimurium VNP20009 L-forms suppress tumor growth and metastasis by inhibiting TGF-β1/Snail/Vimentin pathway in murine lung cancer
Wei Zhao, Qin Chen, Cuiping Yang, Yifan Chu et al.
2026-10 · DOI: 10.1016/j.ejphar.2026.179240Social cognition as an under-used behavioural endpoint in neurodevelopmental psychopharmacology: A conditional framework for integrating theory of mind into clinical trial design
Berkan Sahin
2026-10 · DOI: 10.1016/j.ejphar.2026.179270The natural coumarin 7-methoxy-8-isopentenyloxycoumarin alleviates LPS-induced inflammation by suppressing NF-κB and the MAPK/AP-1 pathways and accelerating COX-2 proteasomal degradation
Shiu-Wen Huang, Hsiu-Chen Chen, Antonio Lupia, Rita Meleddu et al.
2026-10 · DOI: 10.1016/j.ejphar.2026.179266Astrocytes in the ventral posterolateral nucleus modulate diabetic neuropathic pain in male rats and are inhibited by the analgesic koumine
Jian Chen, Jingshan Lu, Xiaona Mo, Jinxing Chen et al.
2026-10 · DOI: 10.1016/j.ejphar.2026.179262Precision genome editing strategies for enduring lipid lowering in atherosclerosis
Durlav Chowdhury, Nirdesh Singh, Swarnalata Garai, Devi Prasad Pandey et al.
2026-10 · DOI: 10.1016/j.ejphar.2026.179312Zonisamide improves cognitive impairment and psychiatric symptoms related with SAPAP3 in mouse models of Alzheimer's disease
Fangtai Yi, Jianfeng Ma, Ruiyue Zhao, Qiuyu Xie et al.
2026-10 · DOI: 10.1016/j.ejphar.2026.179279Finerenone ameliorated ventricular remodeling post myocardial infarction in rats by reducing NF-KB pathway-mediated pyroptosis
Xue Sun, Linlin Song, Qipei Liu, Nuo Chen et al.
2026-10 · DOI: 10.1016/j.ejphar.2026.179280The role and mechanism of rosiglitazone in endothelial-to-mesenchymal transition in pulmonary hypertension
Aoxue Yuan, Yaqian Bai, Yuanhang Jiang, Shengnan Si et al.
2026-10 · DOI: 10.1016/j.ejphar.2026.179227Reviews
Community Reviews
Version History
September 8, 2026 at 12:01 am
September 8, 2026